CBM - Cambrex Corp.

CBM valuation $695.23 million

Stock Price

22.43
Change: ↓ -0.44 (-1.9239%)
Last Update: 2015-01-30T16:15:25-05:00
Shares Outstanding: 30,995,575
Industry: Biotechnology

Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.  The Company offers Active Pharmaceutical Ingredients (“APIs”), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. 

Stock Price Data

Open: 22.61 Previous Close: 22.87
High: 22.75 Low: 22.34
Bid: 22.43 Ask: 25.00

Bid Size: 200 Ask Size: 100
Raw Bid Size: 2 Raw Ask Size: 1
Trade Volume: 2123 Share Volume: 225906
Last Trade Date: 2015-01-30 Last Trade Time: 16:00:59-05:00
Vwap: 22.5161526 EPS: 1.22

Fundamental Data

PE ratio: 18.20 PB ratio: 2.991
Beta: 0.761648

52 Week High: 24.45 52 Week Low: 15.7601
52 Week High Vwap: 24.0322 52 Week Low Vwap: 16.5571
52 Week High Volume: 2851312 52 Week Low Volume: 50458
52 Week Avg Volume: 275633
* Quotes delayed 15 minutes

Related Stocks

StockCompany namePrice
GILD Gilead Sciences Inc. 104.83
IMGN ImmunoGen Inc. 7.63
CELG Celgene Corporation 119.16
ARNA Arena Pharmaceuticals Inc. 4.31
MNKD MannKind Corporation 6.35
AMGN Amgen Inc 152.26
NVAX Novavax Inc. 7.81
BIIB Biogen Idec Inc. 389.16
NPSP NPS Pharmaceuticals Inc. 45.86
ARIA ARIAD Pharmaceuticals Inc. 6.45